medicaid glp-1 As demand for weight-loss drugs rises, states grapple with coverage • Missouri Independent Pennsylvania Medicaid stopped covering GLP-1s

doi: 10.1161/HYPERTENSIONAHA.113.00588 96 GaspariTLiuHWelungodaIHuYWiddopREKnudsenLBet al

In a randomized, double-blind, placebo-controlled study, ghrelin infusion had no acute effect on markers of bone turnover in healthy controls

GLP-1 GIP NASH Trial NEJM 2024 View on PubMed 2023 Diabetes Care Mechanism Glucagon Co-Agonism Amplifies GLP-1-Mediated Weight Loss via Brown Adipose Thermogenesis Finding: In mouse models, adding glucagon receptor agonism to GLP-1R agonism increased brown adipose tissue thermogenic gene expression (UCP1 +62%, PGC-1 +44%) and significantly amplified fat oxidation (+38%)

Multiple studies have demonstrated that administering exendin(9-39) was sufficient to normalize postprandial insulin and glucose levels and prevent hypoglycemia in patients who underwent RYGB (111, 112)

Health Disclaimer Shotsy is designed for tracking and educational purposes only

In weight loss patients, it works by mimicking a natural hormone that helps regulate appetite and blood sugar levels